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Abstract
In 2002, we identified 28 people in Nkhotakota District who 
were suffering from Human African Trypanosomiasis (HAT). 
Sixteen of  these were identified when they presented to the 
District Hospital with a febrile illness.  The remaining twelve 
were identified through a rural cross-sectional survey, in 
which 500 people were visited in their homes, persons found 
to be febrile, were examined by blood film microscopy.  
Of  the 28 people, 50% (14) presented within a month of  the 
onset of  symptoms.  Sixteen (57%) had splenomegaly, and 
24 were anaemic ([Hb] <12 g/dl).   Four patients died (14%), 
of  which two were in the late stage of  the disease.
None of  the patients recall having a chancre that could 
be attributed to the bite of  tsetse flies. 9 out of  28 (32%) 
reported illness longer than 90 days. Of  the 9 patients 6 
(66%) of  them remained in the early stage after reporting 
illness of  180 days. This study reports on the prevalence and 
clinical features of  Trypansoma brucei rhodesiense infection in a 
endemic district in Malawi. 
Introduction
Human African trypanosomiasis (HAT) has two modes of  
presentations. Acute presentation usually associated with 
Trypanosoma brucei rhodesiense (T. b. rhodesiense) infection found 
in East and Southern Africa and chronic presentation  usually 
associated with Trypanosoma brucei gambiense (T.b.gambiense) 
mainly found in West and Central Africa. 
There is limited information concerning the prevalence of  
HAT in Malawian districts that are known to have this disease. 
The Central Health Sciences Unit (CHSU) maintains annual 
records of  all positive cases in the country. Previous studies 
have shown that Nkhotakota District Hospital recorded over 
200 cases in 1990 and a steady decline of  cases has been 
observed since1. The reason for this is currently unknown. 
The HAT found in Malawi is mainly transmitted by Glossina 
morsistans group of  tsetse flies2. Following inoculation of  
infective organisms by the fly bite, parasites proliferate at 
the site of  inoculation. This causes a local inflammation 
(chancre) which appears 5 to 15 days at the site of  tsetse 
bite and persists for 2 to 3 weeks3. After that regional lymph 
node swelling may follow which often involves the cervical 
lymph glands (Winterbottom’s sign), but could occur at any 
other site. The next stage is invasion of  the haemolymphatic 
system. This is called the early stage of  the disease. A majority 
of  patients present with symptoms similar to malaria with 
headaches, pains in the neck, shoulders, and calves, irregular 
fever with shivering, sweating and increased pulse rate4. This 
stage is characterised by hepatosplenomegaly and important 
complications may occur such as myocarditis and pericardial 
effusions, in particular in T rhodesiense infection. After that 
the parasites may invade the central nervous system. This 
causes the meningoencephalic, or late, stage of  the disease; 
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this is characterized by the presence of  trypanosomes and 
a moderately raised  white cell count in the cerebral spinal 
fluid.  Patients may develop a spectrum of  neurological 
abnormalities such as sleep disturbance, cranial nerve palsies, 
tremors, ataxia and mental disturbance. Without treatment 
the disease progresses to coma and death. 
We attempted to assess the prevalence of  HAT in one of  the 




Patients with HAT were recruited in Nkhotakota, Central 
Malawi, in 2002, either by  community surveillance (active 
case finding), or by passive case finding among those 
who presented directly at Nkhotakota District Hospital. 
The community surveillance was part of  the on-going 
trypanosomiasis control programme organized by CHSU. 
The surveillance was organized as a follow up of  cases that 
were diagnosed passively. The number of  people screened 
varied from village to village but on average about 100 people 
were screened at anyone time. At the end of  the year about 
500 people were screened. The process was on-going but 
the highest numbers of  people were screened in the rainy 
season when the disease is generally most prevalent. The 
people that had symptoms similar to malaria were screened 
and family contacts regardless of  the symptoms were 
included in the screening process. Blood films were air dried 
and stained on the spot and microscopic examinations were 
conducted at Nkhotakota district hospital laboratory. There 
were 3 independent technicians who looked at each blood 
film. A minimum of  4 microscopic screening attempts were 
made before the sample could be classified as negative. The 
positive cases were admitted to the hospital for staging and 
treatment and no attempt was made to follow up the people 
that had negative results.
Diagnosis of  HAT was by microscopic detection of  
trypanosomes in wet blood films. The film was made by 
collecting a drop of  capillary blood on a slide and spreading 
it evenly on an area 15-20 mm in diameter. The smear was 
allowed to completely dry and was stained using Field’s 
rapid technique for thick blood film or Giemsa-stained 
thick blood films. The preparation was allowed to dry 
and a drop of  immersion oil was spread on the film and 
the film was examined microscopically using the 100X. 
The buffy coat fraction, an upper layer of  serum collected 
after microhematocrit centrifugation, was also examined to 
increase the chances of  detecting the parasites5. Staging of  
the disease was determined by microscopic examination of  
cerebrospinal fluid (CSF) after lumbar puncture6. Patients 
with no trypanosomes in the CSF and white count of  less 
than or equal to 5 cells/mm3 were classified as having early 
stage disease (no CNS involvement) . On the other hand 
the patients that had trypanosomes in the CSF and/or 
white count of  greater than 5 cells/mm3 were classified as 
having late-stage disease. Early stage infections were treated 
with suramin and late stage infections were treated with 
melarsoprol7. Haemoglobin was estimated using Hemocue 
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(Hemocue Ltd, Dronfield, Derbyshire, UK) according to 
manufacturer’s instructions. Stool and urine samples were 
routinely collected for microscope analysis to rule out 
hookworms and other protozoa that can easily be identified 
by microscopy. The same thick film was concurrently 
examined for malaria parasites. 
For statistical analysis, Excel for XP and multinomial logistic 
model were used. The study was approved by the College of  
Medicine Research and Ethics Committee.
Results
A total of  28 patients (16 males [57%], 12 females [43%] were 
diagnosed with HAT, by active (n=12) and passive (n=16) 
case finding. The median age was 23 years (range 2-55 years) 
see table 1. None had concomitant malaria, but most patients 
reported repeated treatment for ‘malaria’ before diagnosis. 
None of  the patients could recall having a chancre that could 
be attributed to the bite of  tsetse flies. 
The majority of  the patients (26) presented with early disease 
(median duration of  symptoms 30 days); only 2 patients 
presented with late stage disease (in the 5th month of  illness) 
see table 2. 50% of  all cases presented within 1 month of  
becoming ill while 32% reported illness longer than 90 days; 
6 of  these  remained in the early stage after reporting illness 
of  180 days. 
24 patients had  Hemoglobin [Hb] levels below 12 g/
dL (mean Hb = 8.96 ± 3.07 g/dl) while 4 had normal 
haemoglobin levels (Hb = 12.17 ± 1.35 g/dl). There was 
no correlation between presence and degree of  anaemia and 
duration of  illness.  Hepatosplenomegaly was found in 16 
patients; those with longer duration were more likely to have 
hepatosplenomegaly.  4 patients died, two with early disease 
died (cause unknown) and two who had late stage disease; 
they were both very anaemic with hepatosplenomegaly.
Parasitological examination of  stool and urine did not reveal 
any abnormality in any of  the patients.  
Discussion
This study shows that only 28 patients were diagnosed with 
HAT in Nkhotakota in 2002 while is in contrast to the 200 
cases that were seen annually in the 1990s. Trypanosomiasis 
is a neglected disease without any active funding in Malawi. 
Disease control, management and surveillance training has 
been through the East Africa Network for Trypanosomiasis 
(EANET). 
There are several features in our patients that are remarkable. 
The duration of  illness is longer than expected in T. rhodesiense 
infection. No patients reported a chancre; while a chancre 
can be absent in T. rhodesiense this has been well described in 
T. Gambiense infection. Anaemia was common and could not 
be explained by concurrent malaria or helminthic infections; 
hepatosplenomegaly was also more common than reported 
in the literature. However no comparison could be made 
with patients without HAT from the same community. As 
HIV is endemic in Malawi it may be speculated that HIV 
related illness as well as malaria may have contributed to 
these clinical features.
It may be hypothesized that in Malawi a more mild form of  
T. b. rhodesiense occurs that has already been reported in the 
past in Zambia8. One can then speculate that people of  Bantu 
descent may have greater tolerance to trypanosome infection, 
because their ancestors are likely to have been exposed to 
human infective trypanosome for several thousands of  years. 
Apart from Malawi and Zambia, T. b. rhodesiense infection 
found in other places usually causes a very acute disease3. It 
is postulated that people of  Nilotic descent, who are found 
in other areas where T.b. rhodesiense is prevalent, have less 
tolerance to the disease as their ancestors migrated into East 
African region from tsetse free areas to the North over the 
past 2,000 years. There is a need for isolation and genotyping 
of  the parasites found in Malawi to confirm the assumption 
that HAT in Malawi is caused by T rhodesiense.
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Table 2. The mode of clinical presentation of Trypanosomiasis patients 
at Nkhotakota District hospital.












>1 14 85.7 %(12) 42.9 % (6) 7.1% (1)
1-2 5 100.0 % (5) 80.0 % (4) 10.5%(1)
3-4 2 50.0 % (1) 0 (0) % 0 %(0)
5-6 5 100.0 % (5) 100.0 %(5) 40% (2)
< 6 2 50.0 % (1) 50.0 % (1) 0 %
Total 
Numbers
28 24 16 4
Table 1 Trypanosomiasis patients. 
Gender (Males:Females) 16:12
Median age (yr)  (Range) 23 (2-55)
No of  Subjects in late  stage (% of total) 2 (7.1)
No of  subjects  with chancre  (% of total) 0 (0)
Median duration of disease  (days) 
(interquanrtile  range)
30 (142)
